Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human

Safety and Efficacy of a Unique Dose of a Brown Seaweeds Powder Enriched in Polyphenols on Human

The primary endpoint of this trial will be to evaluate the safety of a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder when taken 30 minutes before a test meal. The secondary endpoint of this trial will be to evaluate if a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder is able to reduce the rate of carbohydrate absorption as measured by following postprandial glycemia and insulinemia.

Inclusion Criteria:

• Healthy volunteer
• BMI between 20 and 30
• Non-smoking

Exclusion Criteria:

• Iodine allergy
• Diabetes
• Use of dietary supplements for duration of study
• History of major surgeries or surgeries of the stomach or digestive tract